PMID: 6113479Jul 18, 1981Paper

Cuff and ambulatory blood pressure in subjects with essential hypertension

Lancet
J S FlorasP Sleight

Abstract

Clinic cuff blood-pressure measurements, obtained on at least three occasions, were compared with mean arterial pressures in 59 patients with borderline or essential hypertension who underwent direct ambulatory monitoring of blood pressure. In 22 patients (group I) mean cuff and ambulatory pressures were similar (+/- 10 mm Hg) while in 32 subjects (group II) cuff pressures were more than 10 mm Hg higher. Groups I and II could not be distinguished on the basis of clinical examination, indices of sympathetic nerve activity, or blood-pressure variability, or by the magnitude of pressure rise during physical or mental exercise. Group II had less cardiovascular target organ damage and better baroreflex sensitivity but there was considerable overlap. There was no reliable way of telling which subjects would have lower ambulatory than cuff pressures. 20 out of 59 subjects classified as hypertensive by cuff measurements had awake ambulatory pressures or less than 140/90 mm Hg.

Citations

Dec 1, 1991·Cardiovascular Drugs and Therapy·J R Hampton
Jun 1, 1989·Cardiovascular Drugs and Therapy·A J CoatsP Sleight
Dec 1, 1994·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·C L Laffer, F Elijovich
Jan 1, 1986·Behaviour Research and Therapy·A Steptoe, D Molineux
Aug 29, 2003·The American Journal of Cardiology·Ramazan OzdemirHakan Gullu
Sep 18, 2004·Archives of Gerontology and Geriatrics·G TorrisiS Di Mauro
Dec 1, 1986·Journal of the American College of Cardiology·V E SmithM K Karimeddini
Aug 4, 2001·Autonomic Neuroscience : Basic & Clinical·V AnticJ P Montani
Aug 20, 1992·The New England Journal of Medicine·J F Setaro, H R Black
Jun 1, 1991·Medical Anthropology·M Nichter
Apr 1, 1988·Clinical and Experimental Pharmacology & Physiology·R D Gordon
Mar 1, 1990·Clinical and Experimental Pharmacology & Physiology·C A SilagyB P McGrath
Jun 1, 1990·Journal of Epidemiology and Community Health·P R Croft, J K Cruickshank
May 1, 1985·Scandinavian Journal of Primary Health Care·A R Andersen, P E Nielsen
Jan 1, 1985·Clinical and Experimental Hypertension. Part A, Theory and Practice·B WaeberH R Brunner
Jan 1, 1985·Clinical and Experimental Hypertension. Part A, Theory and Practice·R SchmiederA W von Eiff
Jan 1, 1990·Clinical and Experimental Hypertension. Part A, Theory and Practice·K ShimadaT Ozawa
Jan 1, 1991·Clinical and Experimental Hypertension. Part A, Theory and Practice·N P ChauP Larroque
Jan 1, 1991·Clinical and Experimental Hypertension. Part A, Theory and Practice·G PannaraleP Sleight
Jan 1, 1989·Clinical and Experimental Hypertension. Part A, Theory and Practice·I SaitoT Sekihara
Jan 1, 1983·Clinical and Experimental Hypertension. Part A, Theory and Practice·J I DrayerJ L DeYoung
Jan 1, 1989·Clinical and Experimental Hypertension. Part A, Theory and Practice·G Mancia, A Zanchetti
May 15, 2007·Clinical and Experimental Hypertension : CHE·María Paz García-VeraFrancisco J Labrador
Sep 1, 1996·Blood Pressure·A Pose-ReinoJ Cabezas-Cerrato
Jun 12, 2003·Blood Pressure·Raquel Hernández del-ReyHelios Pardell
Jan 1, 1985·Clinical and Experimental Hypertension. Part A, Theory and Practice·T G PickeringJ H Laragh
Jan 1, 1987·Clinical and Experimental Hypertension. Part A, Theory and Practice·Y ImaiK Yamakoshi
Jan 1, 1992·Clinical and Experimental Hypertension. Part A, Theory and Practice·C CardilloG Folli
Jan 1, 1986·Clinical and Experimental Hypertension. Part A, Theory and Practice·J Conway
Oct 29, 1992·The American Journal of Cardiology·S OmboniG Mancia
Oct 1, 1987·American Heart Journal·T G Pickering, R B Devereux
Apr 22, 1991·The American Journal of Cardiology·O TochikuboM Ishii
Sep 1, 1991·Scandinavian Journal of Clinical and Laboratory Investigation·J C BarthélémyJ R Lacour

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.